About this trial
This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
Male or female of 18 years of age or older
Diagnosis of COVID-19 infection by RT- PCR within 1 week of Screening
Disqualifiers
Refusal to sign informed consent form
History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
Postoperative stoma, ostomy, or ileoanal pouch
Treatment with total parenteral nutrition
Trial population
Adults 18 and older
Trial design
Other
Other
Treatments tested in this trial
There is no intervention in this study
Other interventionThere is no intervention in this study
Treatment groups
Trial outcomes
Primary outcomes
Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing
Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized among specific gastrointestinal disease types.
Secondary outcomes
Validation of Sequencing Methods
To validate the methods used to sequence samples
Sponsors and contacts
Click on the lead sponsor to view all of their trials.